News
The University of Sydney and ResMed partner to accelerate research in sleep-disordered breathing and biomedical engineering
May 13, 2013 4:30 pm | by PR Newswire | CommentsSYDNEY, May 13, 2013 /PRNewswire/ -- The University of Sydney and ResMed Limited today announced a new partnership that includes significant and long-term funding of research at the University, ultimately benefitting the hundreds of millions of sufferers of sleep-disordered breathing worldwide.
Breakthrough ‘AffloVest’ Greatly Advances Respiratory Care
May 13, 2013 1:46 pm | by International Biophysics Corporation | CommentsA new high frequency chest wall oscillation vest that gives respiratory patients the freedom to move around during treatments is now available in the United States, International Biophysics Corporation has announced. The AffloVest represents a major advancement in the treatment of respiratory diseases such as Chronic Obstructive Pulmonary Disease, Cystic Fibrosis, chronic bronchitis, and similar related ailments.
Anaesthetists’ Survey Delivers Food for Thought
May 13, 2013 1:23 pm | by Creative Medical Research | CommentsA recent Europe-wide survey of Anaesthetists has revealed a range of issues affecting the profession in relation to existing and future technologies. The 15-minute long survey of 104 anaesthetists from western, northern and southern Europe asked a number of pertinent questions concerning the nature of current technologies and those expected to come on stream in the near future.
The Smart Phone App that Helps Weight Loss
May 13, 2013 12:28 pm | by The University of Liverpool | CommentsResearchers at the University of Liverpool have developed a smart phone app that helps users lose weight by carefully recording their food consumption. The app was developed in response to research from the University’s Institute of Psychology, Health and Society, which showed that paying attention to what you eat while you eat it helps reduce food intake and prevents consuming excess calories at future meals.
Extremely Low 90-Day Cardiac Device Infection Rates with TYRX Antibacterial Envelope Use
May 13, 2013 12:19 pm | by Kureczka/Martin Associates | CommentsUse of TYRX, Inc.'s AIGISRx Antibacterial Envelope reduced major infection rates by more than 90% in patients undergoing Cardiovascular Implantable Electronic Device (CIED) replacement procedures compared to similar high-risk cohorts, according to the CITADEL & CENTURION clinical study results presented on Saturday at the Late Breaking Clinical Trials session at Heart Rhythm 2013.
Reversing Paralysis with a Restorative Gel
May 13, 2013 12:15 pm | by Tel Aviv University | CommentsSome parts of the body, like the liver, can regenerate themselves after damage. But others, such as our nervous system, are considered either irreparable or slow to recover, leaving thousands with a lifetime of pain, limited mobility, or even paralysis.
BioControl Medical Launches New Website to Deepen Patient, Family, Clinician Education on Its Investigational CardioFit® Therapy
May 13, 2013 11:47 am | by The Associated Press | CommentsYEHUD, Israel & NEW HOPE, Minn.--(BUSINESS WIRE)--May 13, 2013--BioControl Medical has unveiled a new corporate website that offers patients, family and clinicians a valuable educational resource on its CardioFit therapy for heart failure (HF), as well as the INOVATE-HF (INcrease Of VAgal TonE...
PatientsLikeMe and CISCRP Team up with Sanofi to Spotlight Medical Heroes and Clinical Trial Participation
May 13, 2013 10:00 am | by The Associated Press | CommentsCAMBRIDGE, Mass.--(BUSINESS WIRE)--May 13, 2013--PatientsLikeMe and the nonprofit Center for Information and Study on Clinical Research Participation (CISCRP) announce a new partnership with global healthcare leader Sanofi (NYSE: SNY) to raise awareness about the benefits of participating in...
Biventricular Pacing Reduces Symptoms and Improves Quality-of-Life
May 13, 2013 9:52 am | by Medtronic | CommentsMedtronic has announced new data demonstrating that simultaneously pacing the lower chambers of the heart, or biventricular (BiV) pacing with a cardiac resynchronization therapy (CRT) device, significantly improves heart failure symptoms and quality of life in a subset of heart failure patients.
New Clinical Studies Presented at the International Anesthesia Research Society Annual Meeting Show Benefits of Masimo Noninvasive Patient Monitoring Technologies: SpHb®, RRa™, and SedLine®
May 13, 2013 8:00 am | by PR Newswire | CommentsIRVINE, Calif., May 13, 2013 /PRNewswire/ -- Masimo (NASDAQ: MASI) announced today that three new clinical studies evaluating Masimo noninvasive patient monitoring technologies were presented before the world's leading anesthesia educators and investigators at the International...
Invuity® Finalist for the 2013 Red Herring Top 100 North America Award
May 13, 2013 8:00 am | by PR Newswire | CommentsSAN FRANCISCO, May 13, 2013 /PRNewswire/ -- Invuity®, a leading developer of advanced visualization devices to optimize minimal access and minimally invasive surgeries, announced today it has been selected as a finalist for Red Herring's Top 100 North America award, a...
TriStar Wellness Solutions Acquires HemCon Medical Technologies
May 13, 2013 7:30 am | by The Associated Press | CommentsWESTPORT, Conn.--(BUSINESS WIRE)--May 13, 2013--TriStar Wellness Solutions, Inc. (OTCBB: TWSI), a health and wellness company that targets opportunities in the self-care and professional marketplace, has acquired HemCon Medical Technologies Inc., a Portland, Oregon-based leading researcher and...
Lincor Solutions Launches World’s First Mobile Solution for Patient Engagement and Clinical Services
May 13, 2013 4:00 am | by The Associated Press | CommentsDUBLIN--(BUSINESS WIRE)--May 13, 2013--Lincor announces the latest addition to the MEDIVista product suite – MEDIVista MOBILE, during eHealth Week in Dublin. MEDIVista MOBILE in use by a patient to access a range of services including live TV and Movies on Demand (Photo: Business Wire) MEDIVista...
Meeting Announcement: July 18, 2013 Dental Products Panel of the Medical Devices Advisory Committee
May 13, 2013 12:00 am | by U.S. Food & Drug Administration | CommentsOn July 18, 2013, the committee will discuss and make recommendations on the proposed regulatory classification for dental devices known as Endosseous Dental Implants (Blade-form), one of the remaining preamendments Class III devices. The Class III blade-form endosseous dental implant is a device placed into the maxilla or mandible and composed of biocompatible material with sufficient strength to support a dental restoration.
A Rise in the Number of the Aged in Asia-Pacific Widens the Market for Home Care Devices, Finds Frost & Sullivan
May 12, 2013 11:53 pm | by PR Newswire | CommentsKUALA LUMPUR, Malaysia, May 12, 2013 /PRNewswire/ -- Acknowledging the rapid aging of the population in Asia-Pacific, governments are encouraging patients to opt for home care by offering incentives, subsidies and tax cuts. While improving patients' quality of life, home care also...
